# Prehospital Tranexamic Acid Use for Traumatic Brain Injury

> **NCT01990768** · PHASE2 · COMPLETED · sponsor: **University of Washington** · enrollment: 967 (actual)

## Conditions studied

- Traumatic Brain Injury

## Interventions

- **DRUG:** 1 gram Tranexamic Acid (TXA)
- **DRUG:** 2 grams TXA
- **DRUG:** 0.9% Sodium Chloride injectable

## Key facts

- **NCT ID:** NCT01990768
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2017-11-07
- **Final completion:** 2017-11-07
- **Target enrollment:** 967 (ACTUAL)
- **Last updated:** 2019-01-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01990768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01990768, "Prehospital Tranexamic Acid Use for Traumatic Brain Injury". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01990768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*